|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 15750560.3 (espacenet) (Federated) (European Patent Register), 20150805 | Patent/reg. no. and date | DK/EP 3177307, 20240717 | Publication date | 20170614 | Priority no. and date | US 201462033726 P, 20140806 | EP pub. no. and date |
EP 3177307 20170614 | Effective date | | Applicant/owner | The University of Miami, 1951 NW 7th Avenue Suite 110
Miami, Florida 33136, US | Applicant ref. no. | PU281323DKQ | Inventor | MALEK, Thomas, 281 Palm Avenue
Miami Beach, Florida 33139, US | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | Opponent | | IPC Class | A61K 38/00 (2006.01) , C07K 14/55 (2006.01) | Title | INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR-ALPHA-FUSIONSPROTEINER OG FREMGANGSMÅDER TIL ANVENDELSE | Int. application no. | US2015043792 | Int. publication no. | WO2016022671 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |